Physician profile
Erdal Cavusoglu
NPI 1417941683
$1,977.59
in general payments reported to CMS, 2019-2025
19 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $434 · 2021: $350 · 2022: $130 · 2023: $159 · 2024: $67.98 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $482.99 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $383.07 | 2019-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $361.18 | 2019-2022 | |
| Abiomed | $233.28 | 2019-2024 | Impella |
| Boston Scientific Corporation | $88.79 | 2022-2023 | Rotapro |
| Shockwave Medical, INC | $76.18 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kestra Medical Technology Services, INC. | $58.86 | 2022-2024 | Assure Wcd |
| Pfizer INC. | $52.27 | 2021 | |
| Impulse Dynamics (USA) INC. | $39.49 | 2025 | Optimizer |
| Alnylam Pharmaceuticals INC. | $36.10 | 2025 | Amvuttra |
| Sensible Medical Innovations INC | $25.60 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.40 | 2025 | |
| Philips North America LLC | $23.66 | 2019 | |
| Medtronic, INC. | $20.42 | 2023 | Corevalve Evolut R |
| Chiesi USA, INC. | $20.00 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16.67 | 2019 | |
| Astellas Pharma US INC | $14.41 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.21 | 2022 | |
| Z-Medica, LLC | $6.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erdal Cavusoglu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.